- Report
- February 2022
- 151 Pages
South Africa
From €2215EUR$2,500USD£1,916GBP
- Report
- January 2022
- 37 Pages
United States
- Report
- January 2022
- 278 Pages
Global
From €3765EUR$4,250USD£3,258GBP
- Report
- January 2022
- 14 Pages
Europe
- Report
- January 2022
- 278 Pages
Global
From €3765EUR$4,250USD£3,258GBP
- Report
- November 2021
- 159 Pages
Global
From €3765EUR$4,250USD£3,258GBP
- Report
- December 2020
- 63 Pages
Germany
From €538EUR$629USD£450GBP
- Report
- December 2020
- 200 Pages
Global
€3943EUR$4,450USD£3,411GBP
- Report
- July 2019
- 26 Pages
China
- Book
- April 2019
- 836 Pages
Canada
- Training
- 120 Minutes
Global
- Training
- 60 Minutes
Global
- Report
- July 2022
- 240 Pages
Global
From €1772EUR$2,000USD£1,533GBP
- Report
- August 2025
Europe
From €1856EUR$2,095USD£1,606GBP
€3535EUR$3,990USD£3,058GBP
- Report
- August 2025
Global
From €1856EUR$2,095USD£1,606GBP
€3535EUR$3,990USD£3,058GBP
- Report
- August 2025
China
From €1856EUR$2,095USD£1,606GBP
€3535EUR$3,990USD£3,058GBP
- Report
- August 2025
United States
From €1856EUR$2,095USD£1,606GBP
€3535EUR$3,990USD£3,058GBP
- Report
- August 2025
United Kingdom
From €1856EUR$2,095USD£1,606GBP
€3535EUR$3,990USD£3,058GBP
- Report
- August 2025
North America
From €1856EUR$2,095USD£1,606GBP
€3535EUR$3,990USD£3,058GBP

The Analgesics market is a sector of the pharmaceutical industry that focuses on the production and sale of drugs used to relieve pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, arthritis, and post-operative pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen.
Analgesics are available in a variety of forms, including tablets, capsules, liquids, and topical creams. Many analgesics are available over-the-counter, while others require a prescription.
The analgesics market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the analgesics market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less Read more